Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical Routine

11 Oct 2011

Abstract excerpt

PURPOSE: Multiple myeloma is an incurable malignant plasma cell disease characterized by survival ranging from several months to more than 15 years. Assessment of risk and underlying molecular heterogeneity can be excellently done by gene expression profiling (GEP), but its way into clinical routine is hampered by the lack of an appropriate reporting tool and the integration with other prognostic factors into a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to HER2/EGFR in Cancer Research
Share to Multiple Myeloma Research and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21986844
DOI: 10.1158/1078-0432.ccr-11-1628

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Gene Expression Profiling in Multiple Myeloma—Reporting of Entities, Risk, and Targets in Clinical RoutinePMID 21986844Read ↗

High-risk disease in newly diagnosed multiple myeloma: beyond the R-ISS and IMWG definitionsSemantic proximity Read ↗

Gene Expression Profiling in Multiple Myeloma: Redefining the Paradigm of Risk-Adapted TreatmentSemantic proximity Read ↗

Prediction of high- and low-risk multiple myeloma based on gene expression and the International Staging SystemSemantic proximity Read ↗

Genome-Wide Identification of Potential Biomarkers in Multiple Myeloma Using Meta-Analysis of mRNA and miRNA Expression DataSemantic proximity Read ↗

Gene Expression Profiles in Myeloma: Ready for the Real World?Semantic proximity Read ↗

Translating a gene expression signature for multiple myeloma prognosis into a robust high-throughput assay for clinical useSemantic proximity Read ↗

Definers and drivers of functional high-risk multiple myeloma: insights from genomic, transcriptomic, and immune profilingSemantic proximity Read ↗

International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple MyelomaSemantic proximity Read ↗

A gene expression signature based on cell-death related gene expression in multiple myelomaSemantic proximity Read ↗

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patientsSemantic proximity Read ↗

A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell linesSemantic proximity Read ↗

Genomic characterization of functional high-risk multiple myeloma patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.